baber/WOPTO huggingface dataset:
Patent JP-3051415-B2 (JP)
IPC: C08G59/72
Filed: 1989-09-14
Granted: 2000-06-12
Abstract: Mixtures, which are stable at ambient temperature, of hot- thermosetting reactive resins for insulating impregnation of electrical materials or for the preparation of moulded materials or of composite materials, which mixtures comprise liquid oligoisocyanate or polyisocyanate compounds and liquid epoxide resins and a latent hardening catalyst which is inactive at ambient temperature and which consists of an addition complex of an amine compound from the group consisting of the amines, the alkylhydrazines and the imidazoles, with a boron halide. The mixtures furthermore comprise a small quantity of maleic anhydride, or the boron halide is boron tribromide, without addition of maleic anhydride. Latent catalyst complexes for these mixtures, formed by the addition complexes of BBr3 and an amine, an alkylhydrazine or an imidazole, their processes of preparation, and the resins obtained from these mixtures. 
<IMAGE>
 (days)
Patent JP-H0728978-B2 (JP)
IPC: D06F33/48
Filed: 1988-10-19
Abstract: An out-of-balance control for a laundry machine in which the input to the control is a current signal which is proportionate to the current drawn by a motor (18) which rotates a perforated drum (10) into which fabric goods are loaded. When the drum is accelerated from a relatively low speed, employed in a washing cycle, to a somewhat higher, distribution speed, the input to the control is a "real time" signal which reflects variations in torque required to rotate the drum. The magnitude of these variations is proportional to load unbalance which can cause radial displacement of the drum, machine vibration and damage to its components. The real time signal is averaged. A differential amplifier (24) then subtracts the "average" signal from the "real time" signal, providing an "unbalance torque" signal of alternating polarity. When the "unbalance torque" signal exceeds a given magnitude, reflecting the maximum permissible centrifugal force to be generated by load unbalance, an "unbalance control" signal is generated. The main control (12) of the machine is responsive to this last signal to reduce the rotational speed of the drum.
Patent JP-4186338-B2 (JP)
IPC: F24F3/14
Filed: 1999-09-17
Granted: 2008-11-26
Abstract: PROBLEM TO BE SOLVED: To improve a coefficient of performance of an absorption type refrigerator. SOLUTION: A first state in which air heated to be dehumidified by first and second absorbers 110, 120 is cooled by a first heat exchanger 161, then cooled to be humidified by a third absorber 130, and the heated air is supplied to a fourth absorber 140 to desorb the moisture absorbed to the absorber 140, and a second state in which air heated to be dehumidified by third and fourth absorbers 130, 140 is cooled by a second heat exchanger 162, then cooled and humidified by the absorber 110, and the heated air is supplied to the absorber 120 to desorb the moisture absorbed to the second absorber are alternately switched. Thus, for example in the first state, since only the absorber 140 is necessary to supply an external heat energy, a heat amount to be externally given can be reduced, and hence coefficient of performance of the absorption type refrigerator is improved.
Patent JP-H0532870-B2 (JP)
IPC: H01R24/00
Filed: 1988-10-31
Abstract: A moving mechanism of a moving plate for forming a contacting state and contact-releasing state in the socket for an electric part is characterized in including a contacting operation lever adapted to perform a horizontal movement operation of the moving plate in one direction, and a contact-releasing operation lever adapted to perform a horizontal movement operation of the moving plate in the other direction, one end of the contacting operation lever being pivotably axially supported on a side surface on one end side of the socket body, the one end of the operation lever being pivotally connected to the side surface of one end side of the moving plate by a transmission shaft, the transmission shaft being disposed such that when the contacting operation lever is pivoted about the supporting shaft, the transmission shaft renders a horizontal movement force to the moving plate so that the moving plate is moved in one direction, furthermore, one end of the contact-releasing operation lever being pivotally axially supported on a side surface of the other side of the socket body, the one end of the operating lever being pivotally connected to the side surface of the other end side of the moving plate by a transmission shaft, the transmission shaft being disposed such that when the contact-releasing operation lever is pivoted about the supporting shaft, the transmission shaft renders a horizontal movement force to the moving plate in the other direction, the contacting operation lever and the contact-releasing operation lever being laid along the side surface of the socket body. <IMAGE>
Patent JP-H0818932-B2 (JP)
IPC: A01N43/80
Filed: 1988-11-04
Abstract: Orthoesters are used to stabilise isothiazolone biocides in compositions which optionally further contain organic solvent for the isothiazolone. These stabilizers allow the reduction or elimination of stabilizer salts, neutralization salts and/or water. The stabilised compositions are useful bactericidal, fungicidal and algaecidal compositions.
Patent JP-H0784408-B2 (JP)
IPC: C07D307/33
Filed: 1991-11-14
Abstract: A process for the preparation of 3,4-dihydroxybutanoic acid (1) and salts thereof from a glucose source containing 1,4-linked glucose as a substituent is described. The process uses an alkali metal hdyroxide and hydrogen peroxide to convert the glucose source to (1). The compound (1) is useful as a chemical intermediate to naturally occurring fatty acids and is used to prepare 3,4-dihydroxybutanoic acid-gamma-lactone (2) and furanone (3), particularly stereoisomers of these compounds. <IMAGE>
Patent JP-2608246-B2 (JP)
IPC: G04G5/00
Filed: 1993-12-09
Granted: 1997-05-07
Abstract: A portable pager for receiving a transmitted signal containing paging and timing data during a short time slot (604) assigned to the pager (20) comprises: timing means (720) for generating a time indicating signal; power up means (722) responsive to the timing means (720) for providing power only during the pager's assigned time slot (604); receiving means (840) coupled to the timing means (720) for detecting the transmitted signal powered by the power up means (720); decoding means (840) powered by the power up means (722) and connected to the receiving means for extracting the paging and timing data from the transmitted signal; first synchronisation means (701) powered by the power up means and responsive to the timing data for synchronizing the timing means; and indicating means (750) powered by the power up means (722) and responsive to the paging data for indicating when a page is detected.
Patent JP-H068481-B2 (JP)
IPC: C22C38/60
Filed: 1989-12-01
Abstract: A soft steel for machine cutting with high machinability performances having a content of C</=0.25%, a content of Mn of 0.8 to 1.5%, a content of P of </=0.1%, a content of S of 0.15 to 0.40%, and a content of Si of 0.05 to 0.40%, expressed in percentages by weight. After finishing of the metal, the inclusions of manganese sulfide are surrounded by a plastic oxide layer of an average composition SiO2: 35 to 45%; Al2O3: 10 to 20%; CaO: 15 to 25%; MnO: 10 to 20%. In producing this grade, after the addition of silicon and manganese, the liquid metal is agitated in the presence of a slag of a composition CaO: 20 to 55%; SiO2: 35 to 65%; Al2O3: 15 to 40%; with a CaO %/SiO2% ratio of about 1.
Patent JP-2840337-B2 (JP)
IPC: A61K31/44
Filed: 1989-12-02
Granted: 1998-12-24
Abstract: The present invention relates to a method of inhibiting tumor metastasis in an animal by administering to an animal in need of such treatment an acylaminoalkylpyridineamides represented by the formula <CHEM> wherein: R1 and R2 are the same or different members of the group consisting of halo, phenyl, substituted phenyl and a <CHEM> group wherein n, m and p are independently an interger of from 1 to 8 provided n + m + p is equal to or less than 10; x is thio or sulfinyl; Alk1 is straight or branched chain lower alkylene of 1 to 6 carbon atoms, R3 is hydrogen or lower alkyl, Alk2 is straight or branched chain alkylene of 1 to 4 carbon atoms; R4 is selected from the group consisting of hydrogen, halo, hydroxy, lower alkyl and lower alkoxy; or a pharmaceutically acceptable salt thereof, in an amount effective to inhibit tumor metastasis.
Patent JP-3916743-B2 (JP)
IPC: H04L47/43
Filed: 1997-11-20
Granted: 2007-05-23
Abstract: An ATM cell boundary identification apparatus and method. The apparatus comprises an idle cell inserting unit for inserting an idle cell into a cell transmitted from an ATM layer to be matched therewith in its speed; a header error cell generating unit for generating a header error cell by means of header information of the cell transmitted from the idle cell inserting unit; a cell scrambling unit for scrambling payload of the cell received from the header error cell generating unit; a transmission framer for converting the cell obtained in the cell scrambling unit to be suitable to a frame E1; a line interfacing unit for transmitting a transmission frame obtained in the transmission framer to a transmission line after converting it into a bipolar transmission signal, and for transmitting the cell received from the transmission line to a reception framer; a reception framer for identifying a boundary of the cell according to each time slot of the cell transmitted from the line interfacing unit to thereby extract a header error cell; and a header error cell detecting unit for detecting the header error cell extracted from the reception framer, and checking whether the extracted cell is effective or not.
Patent JP-2975748-B2 (JP)
IPC: G01R33/54
Filed: 1991-09-30
Granted: 1999-11-10
Abstract: The fluid transport properties of a porous media are determined by NMR imaging showing the fluid transport properties such as fluid velocity, fluid acceleration, fluid jerk, translational self diffusion, sample permeability to fluid transport, etc. <IMAGE>
Patent JP-3243223-B2 (JP)
IPC: G11B19/00
Filed: 1998-11-24
Granted: 2002-01-07
Abstract: A determination is made as to whether or not storage devices (24a ... 24j) of a storage array (14) are positioned in their proper physical locations in the array. To make the determination, a device identifier for each of the storage devices is utilized, together with a generated logical identifier. In a preferred embodiment, the device identifier is the serial number for the storage device and the logical identifier includes a combination of all the device identifiers for a particular logical volume (40) of the storage array (14). Preferably, the logical identifier also includes system status information for use in enhancing fault tolerance. The logical identifier is written or updated upon the occurrence of predetermined events or conditions. Using the device identifiers and the logical identifier, an indication can be provided whenever the proper storage devices are not found in the logical volume (40) whereby corrective action can be taken to avoid improper distribution to or reassembly of data from the logical volume. <IMAGE>
Patent JP-4282854-B2 (JP)
IPC: H04M3/00
Filed: 1999-12-09
Granted: 2009-06-24
Abstract: The bridge (G) second network access system has services (S) within an application server (SCP) communicating with switching nodes of the second network (C1,C2). The bridge passes services by selecting a specialist resource (V) representing the second network establishing a connection between the switching node with the services and the specialist resource.
Patent JP-H0717508-B2 (JP)
IPC: C07D239/50
Filed: 1989-12-01
Abstract: A method for the promotion or acceleration of wound healing by a treatment with minoxidil is disclosed. The minoxidial can be administered by topical application, oral administration, injection or any combination thereof. Treatment with minoxidil is effective for promoting the migration of epithelial cells in a wound or in tissues such as cornea and the like. Methods for identifying binding sites for minoxidil in cells based on their affinity for the compound in attachment or chemotactic assays are described.
Patent JP-2685561-B2 (JP)
IPC: F16H53/02
Filed: 1988-01-22
Granted: 1997-12-03
Abstract: A hollow shaft with torque-transmitting structural components, such as gear wheels, curves, cams or the like, and possibly auxiliary form components, such as bearings, stopping faces, hexagonal or circular contours or the like, comprising an initial tube (12) having a substantially constant wall thickness which is expanded by internal pressure in order to fix, by form-locking and force-locking, the components (14, 18) and to shape the auxiliary form components, whereby the maximal expansion of the tube (12) occurs under the structural elements and the auxiliary form elements and whereby the wall thickness of the tube (12) under the structural elements (14, 18) and any auxiliary form elements (16, 20) is partially increased with respect to the wall thickness of the initial tube by material displacement in the axial direction.
Patent JP-S6358058-B2 (JP)
IPC: B21D51/10
Filed: 1980-06-26
Abstract: Concentric recessing a tube endwall in integrated conveyor idler manufacture inverts the end produced by doming the edges together and is carried out on a blank rotating at forging temperature. To expand the range of suitable blanks and the dimensioning of the end product, forming is in two stages. In the first the domed end (2) of the blank (1) is formed to produce a flat surface (5) larger in diameter (D) than the eventual recess base by amounts between 2R and 3R where R is the free bend radius of the blank wall. - In the second stage, final forming is conjoined with inversion by a press tool (6) of the same shape and size as the eventual recess which is forced into the flat area (5). A friction reducing roller etc (7) works at a tangent to the blank to complete the endwall forming process. Press tool and roller speed ratio should be 0.40 to 0.75. In the pre-forming operation the endwall should be truncatedly coned with the generatrix at 30 - 40 deg. PHI to the main axis. This ensures optimum metal flow and distribution in the final product.(. 1-5)
Patent JP-H0720874-B2 (JP)
IPC: A61K39/42
Filed: 1985-04-09
Abstract: A method is described for the production of large quan- tities of biologic which serves as an immunomodulator and also to decrease the concentration of serum cholesterol and triglycerides. In practice, an animal such as a goat is injected with a virus (preferably a normally immunosuppressive Parvovirus) and allowed to react to the virus for a period of time to generate the biologic in its blood serum; blood is then withdrawn from the animal and the serum fraction thereof, containing the desired biologic, can be used in fractionated or more highly purified form. Examples are also provided of use of the biologic as an immunostimulant and for reducing serum cholesterol and triglycerides.
Patent JP-S6411110-B2 (JP)
IPC: C23C2/00
Filed: 1984-07-23
Abstract: PCT No. PCT/FR84/00176 Sec. 371 Date Nov. 15, 1985 Sec. 102(e) Date Nov. 15, 1985 PCT Filed Jul. 23, 1984 PCT Pub. No. WO85/04427 PCT Pub. Date Oct. 10, 1985.The invention consists in a process for consecutively coating a metal band with at least two different coating alloys, on one production line, whereby, to pass from a first product to the second, a secondary tank (8) containing the second alloy is disposed in the main tank (2). The process is used for the continuous production of coated metal sheets.
Patent JP-3939746-B2 (JP)
IPC: A61K/
Filed: 1992-07-24
Granted: 2007-07-04
Abstract: A compsn. is new, and comprises an antigen (I), except an albumin, mixed with an antigen formulation (II) consisting of: a stabilising detergent; a micelle-forming agent; and a biodegradable and biocompatible oil. (II) is a stable oil-in-water emulsion. Also new is a method for inducing a cytotoxic T-lymphocyte response in a human or animal comprising administering (I) and (II), (II) lacking an immunostimulating peptide component. (I) may be antigenic portions of HIV gp120, malaria antigens, CS protein and Sprorozoite surface protein, influenza antigens, carcinoma P21, etc. (I) also may not include a B-cell lymphoma anitgen.
Patent JP-3254218-B2 (JP)
IPC: B41J2/075
Filed: 1993-07-28
Granted: 2002-02-04
Abstract: Flight time of a stream of ink drops is measured and compared against a set point to determine variations therefrom. Variations due to changes in the ink composition are compensated for by adding or withholding solvent in proportion to the detected change. Changes due to variations in nozzle drive voltage result in the computation and use of a new flight time set point value, if necessary to avoid erroneous corrective action.
Patent JP-H0699890-B2 (JP)
IPC: E02B3/06
Filed: 1986-10-03
Abstract: PCT No. PCT/MC86/00003 Sec. 371 Date Aug. 13, 1987 Sec. 102(e) Date Aug. 13, 1987 PCT Filed Oct. 3, 1986 PCT Pub. No. WO87/02724 PCT Pub. Date May 7, 1987.A breakwater for attenuating the sea-swell effects of waves includes a bottom plate rigidly supporting and adapted to be immersed in a body of water. A generally upwardly extending solid front wall is formed at an upstream edge of the plate and an upper end of the front wall extends above the surface of the body of water. A generally upwardly extending rear wall is formed at a downstream edge of the bottom plate and has a plurality of regularly spaced orifices formed therein. A generally upwardly extending intermediate wall is formed between the front wall and the rear wall and also includes orifices, the front wall and the intermediate wall forming therebetween an energy dissipation basin. The front wall extends above the surface of the body of water so as to prevent the passage of a sea swell above the bottom plate as long as the amplitude of the swell is average. The water between the bottom plate and the bottom surface of the body of water behaves like an inert obstacle whereby at least a portion of an incident sea swell is reflected and any swell wave transmitted downstream is of reduced amplitude.
Patent JP-4090072-B2 (JP)
IPC: A61N1/30
Filed: 1995-06-29
Granted: 2008-05-28
Abstract: A composition comprises an agent to be delivered through a body surface and an electrotransport enhancer having a hydrophobic tail and a polar head of specific characteristics. An electrotransport delivery device is also provided having a reservoir comprising the agent to be delivered and the electrotransport enhancer of the invention. The electrotransport enhancers increase the electrotransport delivery rate of the agent through the surface while reducing the electrical resistance of the surface during electrotransport of the agent.
Patent JP-3753734-B2 (JP)
IPC: A61K49/00
Filed: 1995-04-28
Granted: 2006-03-08
Abstract: For use in imaging sites of diagnostic interest within the body, the present invention provides radionuclide chelators, optionally coupled to targeting molecules such as peptides of the formula:   <IMAGE>
Patent JP-3345419-B2 (JP)
IPC: C07K14/74
Filed: 1992-11-03
Granted: 2002-11-18
Abstract: The present invention provides compositions comprising a peptide having between about 7 and about 20 amino acid residues, the peptide being capable of binding a CD8 molecule on a cytolytic T lymphocyte (CTL) precursor and inhibiting differentiation of the CTL precursor to a mature CTL. The peptides have amino acid sequences substantially homologous to a sequence in an  alpha 3 domain of a human Class I MHC molecule. The sequence from the  alpha 3 domain is preferably between residue 220 and residue 235. The peptides typically comprise the sequences DQTQDTE (SEQ. ID No. 1) or EDQTQDTELVETRP (SEQ. ID No. 2).
Patent JP-3552112-B2 (JP)
IPC: C12R1/91
Filed: 1994-10-17
Granted: 2004-08-11
Abstract: Processing of  beta -amyloid precursor protein ( beta APP) is monitored by detecting the secretion of a soluble amino-terminal fragment or  beta APP (ATF- beta APP) resulting from cleavage of  beta APP at the amino-terminus of  beta -amyloid peptide. Secretion of ATF- beta APP in animal models may be monitored to identify inhibitors of  beta -amyloid production. The ATF- beta APP may be detected using antibodies and other specific binding substances which recognize a carboxy terminal residue on the fragment. Animals expressing the Swedish mutation of  beta APP are described which produce abundant amounts of ATF- beta APP.
Patent JP-H0642917-B2 (JP)
IPC: B65B9/02
Filed: 1990-10-17
Abstract: A method of encapsulating spring units is disclosed. The method comprises inserting an uncompressed spring unit into an insertion device, moving the insertion device between a pair of webs, tightening or tensioning the webs around the insertion device, compressing the spring unit, tightening the webs around the compressed spring unit, withdrawing the insertion device as the webs are tightened, and, while the spring unit is compressed, connecting the webs together.
Patent JP-3341019-B2 (JP)
IPC: A61K31/215
Filed: 1991-09-06
Granted: 2002-11-05
Abstract: Monocyclic aryl compounds having selective LTB4 antagonists properties and comprising an amido substituent, a substituent group having a terminal carboxylic acid or derivative thereof and a lipophilic substituent, therapeutic compositions and methods of treatment of disorders which result from LTB4 activity using the monocyclic aryl compounds are disclosed.
Patent JP-3727068-B2 (JP)
IPC: H04W92/02
Filed: 1996-11-06
Granted: 2005-12-14
Abstract: The invention relates to an interworking function apparatus (IWF), a method and an arrangement for establishing a mobile-terminating call in a mobile communications network when the call is received from a calling party via a fixed network without any signalling support which provides information on the protocol employed by the calling party. In the invention, a service is assigned only one directory number, which is common to all the protocols employed by the service. The protocol identifier in a service definition linked with this directory number has a neutral (undefined) value or may be interpreted as neutral. The IWF, upon receiving the neutral RA parameter (Step 2), is switched onto the line and monitors a traffic channel received from the fixed network in order to identify the protocol employed by the calling terminal equipment (Steps 54-57). After identifying the protocol, the IWF is configured according to the identified protocol (Steps 58-60 or 61-63), and data transfer may begin (Step 64).
Patent JP-3802927-B2 (JP)
IPC: A23L33/20
Filed: 1995-03-14
Granted: 2006-08-02
Abstract: PCT No. PCT/DK95/00118 Sec. 371 Date Sep. 16, 1996 Sec. 102(e) Date Sep. 16, 1996 PCT Filed Mar. 14, 1995 PCT Pub. No. WO95/25084 PCT Pub. Date Sep. 21, 1995Organic compounds containing at least one hydrophilic group are rendered soluble in fatty systems by the formation of a chemical complex with a carrier selected among fatty acid esters of polyhydric hydroxyalkanes having general formula (I) wherein R1 is H or -CH2OR5, R2 is H or -CH2OR6, and each of R3, R4, R5 and R6 is independently a saturated or unsaturated fatty acid moiety having 1-30 carbon atoms or a saturated fatty acid moiety having 1-3 carbon atoms, with the proviso that at least one of R3, R4, R5 and R6 is a saturated or unsaturated fatty acid moiety having 1-30 carbon atoms, R2 and at least one or, when any of R1 and R2 is not H, at least two of R3, R4, R5 and R6 is a saturated fatty acid moiety having 1-3 carbon atoms. Diacetates of common monoglycerides are especilally preferred as the carriers for forming such complexes. The complexes are applicable for the incorporation of compounds containing hydrophilic groups into e.g. pharmaceuticals, cosmetics, foodstuffs and feeds, diet supplements and natural medicines as well as technochemical compositions.